Total Payments
$11,975
2024 Payments
$3,249
Companies
52
Transactions
754
Medicare Patients
678
Medicare Billing
$56,386
Payment Breakdown by Category
Food & Beverage$11,865 (99.1%)
Education$109.99 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,865 | 752 | 99.1% |
| Education | $109.99 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,192 | 130 | $0 (2024) |
| Novo Nordisk Inc | $1,222 | 92 | $0 (2024) |
| Lilly USA, LLC | $936.30 | 55 | $0 (2024) |
| PFIZER INC. | $816.21 | 61 | $0 (2024) |
| GlaxoSmithKline, LLC. | $732.45 | 41 | $0 (2024) |
| Amgen Inc. | $606.60 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $445.11 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $415.60 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $380.44 | 27 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $369.27 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,249 | 202 | ABBVIE INC. ($591.61) |
| 2023 | $4,121 | 228 | ABBVIE INC. ($868.54) |
| 2022 | $2,132 | 147 | ABBVIE INC. ($536.70) |
| 2021 | $2,473 | 177 | Novo Nordisk Inc ($386.76) |
All Payment Transactions
754 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Neuromodulation | ||||||
| 12/23/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Inflammation | ||||||
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: DIABETES | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: VACCINE | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: DIABETES | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Narcoplepsy | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $3.73 | General |
| Category: Bone Health | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ANTIBIOTIC | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 136 | 153 | $31,225 | $10,287 |
| 2022 | 4 | 211 | 248 | $52,985 | $19,182 |
| 2021 | 4 | 204 | 245 | $46,443 | $18,223 |
| 2020 | 5 | 127 | 138 | $24,760 | $8,695 |
Total Patients
678
Total Services
784
Medicare Billing
$56,386
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $11,165 | $3,663 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 61 | $9,760 | $3,136 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 31 | $7,308 | $2,259 | 30.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $1,793 | $791.23 | 44.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 15 | $1,199 | $437.04 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $35,090 | $11,806 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 49 | 69 | $10,557 | $4,525 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 53 | $6,042 | $2,343 | 38.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 16 | $1,296 | $508.46 | 39.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 93 | 123 | $18,819 | $8,108 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 69 | 69 | $22,011 | $7,586 | 34.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 40 | $4,560 | $2,083 | 45.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,053 | $447.24 | 42.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 64 | $9,792 | $4,093 | 41.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $10,527 | $3,181 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $1,596 | $550.66 | 34.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 14 | $1,792 | $500.60 | 27.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 13 | $1,053 | $369.98 | 35.1% |
About Stacey Coyle, CRNP
Stacey Coyle, CRNP is a Family healthcare provider based in Sewickley, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2019. The National Provider Identifier (NPI) number assigned to this provider is 1316585474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacey Coyle, CRNP has received a total of $11,975 in payments from pharmaceutical and medical device companies, with $3,249 received in 2024. These payments were reported across 754 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($11,865).
As a Medicare-enrolled provider, Coyle has provided services to 678 Medicare beneficiaries, totaling 784 services with total Medicare billing of $56,386. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Sewickley, PA
- Active Since 12/19/2019
- Last Updated 01/28/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316585474
Products in Payments
- VRAYLAR (Drug) $1,205
- ELIQUIS (Drug) $815.35
- MOUNJARO (Drug) $638.95
- TRELEGY ELLIPTA (Drug) $622.50
- Ozempic (Drug) $567.00
- XIFAXAN (Drug) $369.27
- UBRELVY (Drug) $368.94
- JARDIANCE (Drug) $337.67
- Otezla (Drug) $328.04
- NURTEC ODT (Drug) $302.32
- PROCLAIM (Device) $295.54
- QULIPTA (Drug) $284.79
- SPRAVATO (Drug) $280.33
- Rybelsus (Drug) $267.57
- EVENITY (Biological) $250.76
- Kerendia (Drug) $225.75
- QUVIVIQ (Drug) $188.47
- LINZESS (Drug) $185.04
- Vascepa (Drug) $179.03
- XARELTO (Drug) $164.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sewickley
Dr. Amy Rich, Dnp, Crnp, DNP, CRNP
Family — Payments: $11,307
Family $11,307
Erin Mcdonough-Mayo
Family — Payments: $5,716
Family $5,716
Brooke Kocher, Crnp, CRNP
Family — Payments: $823.97
Family $823.97
Crystle Harcar, Dnp, Np-C, DNP, NP-C
Family — Payments: $734.20
Family $734.20
Victoria Doan, Fnp-C, FNP-C
Family — Payments: $532.92
Family $532.92
Angela Ersher, Crnp, CRNP
Family — Payments: $253.91
Family $253.91